Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Leukemia
Study Phase
Phase 3
Study Completion Date
August 2018
NCT01886872Uploaded 02-09-2020
Access via NCI by Request
PDS UID: nci-data-400
A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
Files: NCT01886872-D5
Data DictionaryNCT01886872-D5-Data-Dictionary_0.pdf
DATANCT01886872-D5-Dataset_0.csv
OTHERREADME.pdf
Files: NCT01886872-D4
Data DictionaryNCT01886872-D4-Data-Dictionary_0.pdf
DATANCT01886872-D4-Dataset_0.csv
OTHERREADME.pdf
Files: NCT01886872-D3
Data DictionaryNCT01886872-D3-Data-Dictionary_0.pdf
DATANCT01886872-D3-Dataset_0.csv
OTHERREADME.pdf
Files: NCT01886872-D2
Data DictionaryNCT01886872-D2-Data-Dictionary_0.pdf
DATANCT01886872-D2-Dataset_0.csv
OTHERREADME.pdf
Files: NCT01886872-D1
Data DictionaryNCT01886872-D1-Data-Dictionary_0.pdf
DATANCT01886872-D1-Dataset_0.csv
OTHERREADME.pdf